May 1, 2024, 07:24
Myeloma Paper of the Day, April 30th, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day: Genomic profiling of high-risk SMM patients who got intensive treatment shows DIS3, FAM46C, FGFR3 mutations, t(4;14) and 1q alterations enriched in HR SMM, NRAS mutations and co-occurrence t(4;14)/FGFR3 mutations associated with increased progression.”
Proceed to the article.
Source: Robert Orlowski/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 18, 2024, 22:22
Nov 18, 2024, 22:02
Nov 18, 2024, 21:55
Nov 18, 2024, 20:54
Nov 18, 2024, 18:36
Nov 18, 2024, 18:32